We are live on ! Find out more
KRSA icon

Korsana Biosciences

95 hedge funds and large institutions have $223M invested in Korsana Biosciences in 2019 Q2 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.06% more ownership

Funds ownership: 0% → 71.06% (+71%)

Holders
95
Holders Change
+95
Holders Change %
–
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
95
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KRSA Hedge Fund Activity: Q2 2019 in Review

95 of the 4,627 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences (KRSA) for Q2 2019, worth a combined $223M.

Buyers outnumbered sellers: 95 funds opened new KRSA positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $38.7M.

  • 95 institutional investors held Korsana Biosciences (KRSA) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $223M of Korsana Biosciences stock for Q2 2019.
  • 95 funds opened new Korsana Biosciences positions in Q2 2019 and 0 closed out, a net change of +95 holders.
  • The largest Korsana Biosciences buyer in Q2 2019 was Fidelity Investments, an estimated $38.7M added.

Based on aggregated 13F filings for Q2 2019.